Emflaza and Pruritus aggravated - a phase IV clinical study of FDA data

Summary:

Pruritus aggravated is reported as a side effect among people who take Emflaza (deflazacort), especially for people who are male, 10-19 old, have been taking the drug for 1 - 2 years also take Vitamin D3, and have Headache.

The phase IV clinical study analyzes which people have Pruritus aggravated when taking Emflaza. It is created by eHealthMe based on reports of 4,041 people who have side effects when taking Emflaza from the FDA, and is updated regularly.

What is Emflaza?

Emflaza has active ingredients of deflazacort. eHealthMe is studying from 4,044 Emflaza users. Check the latest studies of Emflaza.

What is Pruritus aggravated?

Pruritus aggravated (serious severe itching of the skin) is found to be associated with 2,483 drugs and 1,070 conditions by eHealthMe. Check the latest studies of Pruritus aggravated.

On Aug, 02, 2026

4,041 people reported to have side effects when taking Emflaza.
Among them, 25 people (0.62%) have Pruritus aggravated.

Could Emflaza cause Pruritus aggravated?

Among these 25 people:

How long have people been on Emflaza when they have Pruritus aggravated? *

What is the gender of people who have Pruritus aggravated when taking Emflaza? *

female: 0.0 %
male: 100 %

What is the age of people who have Pruritus aggravated when taking Emflaza? *

What are other drugs people take besides Emflaza? *

What are other side effects people have besides Pruritus aggravated? *

Rashes (redness): 12 people, 48.00%
Hypersensitivity: 5 people, 20.00%
Abnormal Behavior: 4 people, 16.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 12.00%
Drug Hypersensitivity: 3 people, 12.00%
Nausea And Vomiting: 2 people, 8.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 8.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 8.00%
Haematochezia (passage of stools containing blood): 2 people, 8.00%
Drug Ineffective: 2 people, 8.00%

What are the existing conditions these people have? *

Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 1 person, 4.00%
Pain In Extremity: 1 person, 4.00%
Pain: 1 person, 4.00%
Nausea And Vomiting: 1 person, 4.00%
Nausea (feeling of having an urge to vomit): 1 person, 4.00%
Muscle Aches (muscle pain): 1 person, 4.00%
Migraine (headache): 1 person, 4.00%
Headache (pain in head): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Emflaza and have Pruritus aggravated?

- Check whether Pruritus aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emflaza:

Emflaza (4,044 reports)

Browse all side effects of Emflaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pruritus aggravated:

Pruritus aggravated (2,483 drugs)

Browse all the conditions that are associated with Pruritus aggravated:

Pruritus aggravated (1,070 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on deflazacort (the active ingredients of Emflaza) and Emflaza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.